Glickman Urological & Kidney Institute Outcomes
Surgical Quality Improvement
Urologic Surgery Outcomes
Urologic Surgery ACS NSQIP Outcomes
January 1, 2022 – December 31, 2022
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s urologic surgery ACS NSQIP performance benchmarked against 590 participating sites.
| Urologic Surgery (590 Sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Morbidity | 709 | 8.74% | 9.92% |
| Cardiac | 709 | 0.42% | 0.72% |
| Pneumonia | 708 | 0.71% | 0.86% |
| Unplanned Intubation | 708 | 0.42% | 0.61% |
| Ventilator > 48 Hours | 708 | 0.56% | 0.29% |
| Deep Vein Thrombosis (DVT) / Pulmonary Embolus | 709 | 1.41% | 1.32% |
| Renal Failureᵇ | 709 | 3.24% | 2.02% |
| Urinary Tract Infection (UTI)ᵃ | 709 | 1.13% | 2.47% |
| Surgical Site Infection (SSI) | 707 | 2.40% | 3.72% |
| Sepsis | 706 | 2.27% | 2.72% |
| C.diff Colitis | 709 | 0.56% | 0.47% |
| Unplanned Reoperation | 709 | 1.13% | 2.19% |
| Unplanned Readmissionᵇ | 709 | 11.71% | 8.05% |
American College of Surgeons National Surgical Quality Improvement Program, 2023.
ACS NSQIP® Semiannual Report July 3, 2023, Chicago: American College of Surgeons.
ᵃIdentified as a statistical outlier (lower than expected) by the ACS NSQIP hierarchical model.
ᵇIdentified as a statistical outlier (higher than expected) by the ACS NSQIP hierarchical model.
